The Cancer Research Technology Program (CRTP) develops and implements emerging technology, cancer biology expertise and research capabilities to accomplish NCI research objectives. In addition, the CRTP hosts the Nanotechnology Characterization Laboratory (NCL) which performs and standardizes preclinical efficacy and toxicity testing of nanoparticles intended for cancer therapeutics and diagnostics. CRTP scientists also work collaboratively with intramural NCI investigators to provide research technologies and expertise.
The Nanotechnology Characterization Lab (NCL) serves as a national resource and knowledge base for all cancer researchers to facilitate the regulatory review of nanotechnologies intended for cancer therapies and diagnostics. By providing the critical infrastructure and characterization services to nanomaterial providers, the NCL accelerates the transition of basic nanoscale particles and devices into clinical applications.
The Nanotechnology Characterization Lab (NCL) provides nanotechnology formulation and characterization services for universities and the pharmaceutical industry (http://ncl.cancer.gov).
The Bioanalytical Chemist will:
- Provide nanoformulation and bioanalytical support for NCL's pharmaceutical customers
- Assist in chemical characterization and development of new bioanalytical methods for evaluating nanomedicines.
To be considered for this position, you must minimally meet the knowledge, skills, and abilities listed below:
- Possession of a Bachelor's degree in pharmaceutical science, chemistry, biochemistry, biology or related discipline from an accredited college or university, according to the Council for Higher Education Accreditation. (Additional qualifying experience may be substituted for the required education)
- Foreign degrees must be evaluated for U.S. equivalency
- In addition to the education requirements, a minimum of five (5) years of experience is required
- Demonstrated background in analytical and/or bioanalytical chemistry; extensive experience with preparation of biological samples for quantification of small molecule drugs, including methods such as HPLC, LC-MS/MS, LLE, SPE
- Experience analyzing, preparing and summarizing analytical data
- Must be able to obtain and maintain a clearance
Candidates with these desired skills will be given preferential consideration:
- Familiarity with drug development and the pharmaceutical industry
- demonstrated analytical problem solving skills
- ability to multi-task and work with a diverse research group
- excellent coordination and communication skills
- Some knowledge of drug metabolism-pharmacokinetics (DMPK)
- ability to work independently in a cross-disciplinary setting
Leidos is a global science and technology solutions leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 33,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported pro forma annual revenues of approximately $10 billion for the fiscal year ended January 1, 2016 after giving effect to the recently completed combination of Leidos with Lockheed Martin's Information Systems & Global Solutions business (IS&GS). For more information, visit www.Leidos.com. The company's diverse employees support vital missions for government and commercial customers. Qualified women, minorities, individuals with disabilities and protected veterans are encouraged to apply. Leidos will consider qualified applicants with criminal histories for employment in accordance with relevant Laws. Leidos is an Equal Opportunity Employer.